U.S. RESEARCH ROUNDUP-BlackRock, Goldman Sachs, Netflix

Ameriprise Financial

16/07/2024 08:29

July 16 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including BlackRock, Goldman Sachs and Netflix, on
Tuesday. 
    
    HIGHLIGHTS
                 * Ameriprise Financial Inc  AMP.N : RBC raises target price to $487 from $480
 
                 * BlackRock  BLK.N : JP Morgan raises target price to $774 from $756    
 
                 * Goldman Sachs  GS.N : HSBC raises target price to $527 from $493
 
                 * Moody's Corp  MCO.N : JP Morgan raises target price to $500 from $415        
 
                 * Netflix Inc  NFLX.O : Jefferies raises target price to $780 from $655    
 
        
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order. 
    
                 * 10X Genomics Inc  TXG.O : TD Cowen cuts target price to $20 from $32
 
                 * Ameriprise Financial Inc  AMP.N : RBC raises target price to $487 from $480
 
                 * BlackRock  BLK.N : JP Morgan raises target price to $774 from $756
 
                 * BlackRock  BLK.N : TD Cowen cuts target price to $960 from $966
 
                 * Broadcom  AVGO.O : Oppenheimer adjusts PT to $200 from $2000 to reflect 10-for-1 stock split
 
                 * Broadcom  AVGO.O : TD Cowen adjusts PT to $210 from $1750 to reflect 10-for-1 stock split
 
                 * Bruker Corp  BRKR.O : TD Cowen cuts target price to $74 from $80
 
                 * Cooper Companies Inc  COO.O : Jefferies raises target price to $115 from $107
 
                 * Gaming and Leisure Properties Inc  GLPI.O : Scotiabank raises target price to $50 from $48
 
                 * Genedx Holdings Corp  WGS.O : TD Cowen raises target price to $46 from $24
 
                 * Generac Holdings Inc  GNRC.N : Canaccord Genuity raises target price to $177 from $150
 
                 * Goldman Sachs  GS.N : Barclays raises target price to $565 from $493
 
                 * Goldman Sachs  GS.N : HSBC raises target price to $527 from $493
 
                 * Goldman Sachs  GS.N : Jefferies raises target price to $571 from $523
 
                 * Goldman Sachs  GS.N : JP Morgan raises target price to $464 from $461
 
                 * Goldman Sachs  GS.N : RBC raises target price to $500 from $435
 
                 * Guardant Health Inc  GH.O : TD Cowen raises target price to $41 from $37
 
                 * Incyte Corp  INCY.O : JP Morgan cuts target price to $59 from $60
 
                 * J & J Snack Foods Corp  JJSF.O : Benchmark cuts target price to $200
 
                 * Lexeo Therapeutics Inc  LXEO.O : Leerink Partners raises target price to $22 from $19
 
                 * Moody's Corp  MCO.N : JP Morgan raises target price to $500 from $415
 
                 * MSCI Inc  MSCI.N : JP Morgan raises target price to $590 from $540
 
                 * Myriad Genetics Inc  MYGN.O : TD Cowen raises target price to $28 from $23
 
                 * Netflix Inc  NFLX.O : Jefferies raises target price to $780 from $655
 
                 * Park Hotels & Resorts Inc  PK.N : JP Morgan cuts target price to $16 from $17
 
                 * PPG Industries Inc  PPG.N : RBC cuts target price to $140 from $141
 
                 * Progressive Corp  PGR.N : HSBC raises target price to $228 from $227
 
                 * Quanterix Corp  QTRX.O : TD Cowen cuts target price to $17 from $20
 
                 * Revolution Medicines Inc  RVMD.O : Jefferies raises target price to $73 from $63
 
                 * Revolution Medicines Inc  RVMD.O : Leerink Partners raises target price to $53 from $48
 
                 * Revolution Medicines Inc  RVMD.O : Oppenheimer raises target price to $55 from $45
 
                 * Revolution Medicines Inc  RVMD.O : Piper Sandler raises target price to $57 from $43
 
                 * Revolution Medicines Inc  RVMD.O : Wedbush raises target price to $59 from $46
 
                 * S&P Global Inc  SPGI.N : JP Morgan raises target price to $550 from $500
 
                 * Select Medical Holdings Corp  SEM.N : Benchmark raises target price to $48
 
                 * Servisfirst Bancshares Inc  SFBS.N : Piper Sandler raises target price to $70 from $63
 
                 * Solid Biosciences Inc  SLDB.O : Leerink Partners raises target price to $28 from $12
 
                 * Wag! Group Co  PET.O : Roth MKM cuts target price to $3.5 from $4
 
                 * Waters Corp  WAT.N : TD Cowen cuts target price to $325 from $358
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))